Avalyn Pharma Inc. Common Stock

AVLN | NASDAQ

$26.12

+$0.49 (+1.91%)

Nov 2, 2026, 9:55 AM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
PE Ratio	-25.52	-46.08
PEG Ratio	-16.33	n/a
PS Ratio	n/a	n/a
PB Ratio	3.66	-4.67
P/FCF Ratio	-25.81	-40.82
P/OCF Ratio	-26.08	-41.25
OCF/S Ratio	n/a	n/a
Debt / Equity Ratio	0.04	-0.06
Quick Ratio	33.10	11.03
Current Ratio	33.10	11.03
Asset Turnover	n/a	n/a
Interest Coverage	-115.04	-284.79
Return on Equity	-7.26%	10.17%
Return on Assets	-6.80%	-19.81%
Return on Invested Capital	-7.53%	-22.44%
Dividend Yield	n/a	n/a
Payout Ratio	n/a	n/a
FCF Payout Ratio	n/a	n/a
Gross Profit Margin	n/a	n/a
Net Profit Margin	n/a	n/a
Pretax Profit Margin	n/a	n/a
Operating Profit Margin	n/a	n/a
FCF Margin	n/a	n/a
EBITDA Margin	n/a	n/a